March 16, 2022 -
For decades, scientists have hypothesized about a future when diseases could be treated with gene editing techniques. The reality is getting closer to fruition! In this fascinating episode, Drs. Eric Kmiec and Natalia Rivera-Torres at ChristianaCare’s Gene Editing Institute share the latest developments in DNA alteration and explain why CRISPR gene editing continues to offer the most promise. They also detail how their lab’s pioneering work in squamous cell carcinoma is leading to what will be the first-ever lung cancer patient trial using CRISPR gene editing in a solid tumor.
Brought to you by the American Lung Association and HCPLive
Tune in and subscribe on:
Have an idea for a future Lungcast episode? Share your idea with us!
